Key facts
- This page summarizes Jorey Chernett's Form 4/A - Amendment filing for Starling Oncology, Inc. (STLN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Nov 2026, 21:43.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Additional SEC filing notes
Section 16 status
Jorey Chernett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer.
SEC remarks
This Form 4/A is being filed solely to indicate that the Reporting Person is no longer subject to Section 16 reporting obligations and constitutes an exit filing for the Reporting Person.